Brief: Alkem Labs Buys Shares In Enzene Biosciences For 3 Billion Rupees
26/12/2025 13:48
Dec 26 (Reuters) - Alkem Laboratories Ltd ALKE.NS: BUYS SHARES IN ENZENE BIOSCIENCES FOR 3 BILLION RUPEES Source text: ID:nBSE2whgzq Further company coverage: ALKE.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees